Company Data
Sage Therapeutics Inc.
Ticker
SAGE
Current Price
$6.46 -0.92%
Market Cap
$404.5M
Price Target
Refer to Report
Volume
612.2K
52wk Range
$4.62 - $13.47
Overview
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the study of the nervous system and brain to discover medicines to treat life-threatening, rare central nervous system disorders. The company’s lead development program is SAGE-217 program which is in Phase 3 clinical trials for post-partum depression, essential tremor, Parkinson’s disease, and major depressive disorder. The company is also developing several other compounds for treatment that are in the early stage of development.